SCHEMBL23093836

SCHEMBL23093836

Cc1nc(N2C[C@@H](C)O[C@@H](C)C2)n2c1cnc1ccc(-c3ccc(N4CCC(NC(C)C)CC4)nc3)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 6/20 0.40
▸ ATR Q13535 4/20 0.40
▸ MTOR P42345 2/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PRKDC P78527 1/20 0.40
▸ ATRIP Q8WXE1 1/20 0.40
▸ TLR9 Q9NR96 4/20 0.40
▸ TLR8 Q9NR97 4/20 0.40
▸ TLR7 Q9NYK1 4/20 0.40
▸ AOC3 Q16853 3/20 0.39
▸ PIK3CA P42336 1/20 0.38
▸ ACVR1 Q04771 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.35
▸ DYRK1A Q13627 3/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ SYK P43405 1/20 0.33
▸ CLK2 P49760 1/20 0.32
▸ CLK3 P49761 1/20 0.32
▸ WNT1 P04628 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29688223 1.00 ATM (0.40) ATMATRMTORPIK3CBPRKDC
SCHEMBL23093838 0.91 AOC3 (0.39) ATMATRMTORPIK3CBPRKDC
SCHEMBL29688040 0.91 AOC3 (0.39) ATMATRMTORPIK3CBPRKDC
SCHEMBL29688366 0.89 AOC3 (0.37) ATMATRMTORPIK3CBPRKDC
SCHEMBL23093832 0.89 AOC3 (0.37) ATMATRMTORPIK3CBPRKDC
SCHEMBL23093845 0.88 AOC3 (0.40) ATMATRMTORPIK3CBPRKDC
SCHEMBL29688031 0.88 AOC3 (0.40) ATMATRMTORPIK3CBPRKDC
SCHEMBL28793983 0.87 AOC3 (0.38) ATMATRMTORPIK3CBPRKDC
SCHEMBL23119292 0.86 ATM (0.46) ATMATRMTORPIK3CBPRKDC
SCHEMBL23119287 0.86 ATM (0.46) ATMATRMTORPIK3CBPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114787162-A Substituted imidazoquinoxaline compounds and uses thereof 上海瑛派药业有限公司 2022-07-22 — — CN claimed
EP-4028400-A1 SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF Impact Therapeutics (Shanghai), Inc (CN) 2022-07-20 — — EP claimed
WO-2021047646-A1 SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF IMPACT THERAPEUTICS, INC (CN) 2021-03-18 — — WO claimed
CN-114787162-A Substituted imidazoquinoxaline compounds and uses thereof 上海瑛派药业有限公司 2022-07-22 — — CN disclosed
EP-4028400-A1 SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF Impact Therapeutics (Shanghai), Inc (CN) 2022-07-20 — — EP disclosed
WO-2021047646-A1 SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF IMPACT THERAPEUTICS, INC (CN) 2021-03-18 — — WO disclosed
Send feedback